These building blocks are essential to modern therapeutics, including fast-growing GLP-1 treatments for weight loss and diabetes
The Healey ALS Platform Trial is a multicenter, double-blind, placebo-controlled
This partnership strengthens LMS as a leading CDMO supplier of peptide materials for both innovator and generic markets
The investigational therapy uses SteadyTeq, a proprietary copolymer technology from Medincell designed to release olanzapine steadily over time
India has deep strengths in reverse engineering and API development, while Russia has strong capabilities in certain vaccines, biologicals, and niche therapeutic segments. Collaboration can significantly shorten R&D timelines
The agreement pairs Croda’s global footprint and “smart science” approach with Amino’s precision manufacturing capabilities
The partnership also allows both companies to explore CR-001 and SKB105 as monotherapies and in combination
The study met its primary endpoint and all 11 secondary efficacy endpoints
The one-time CAR T cell infusion now becomes the first and only therapy of its kind cleared for this patient population
Grant of Permission to manufacture and market FDC of Naproxen Delayed Release and Esomeprazole capsule (375mg/500mg + 20mg/20mg)
Subscribe To Our Newsletter & Stay Updated
